Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Tim McCarthy - LifeSci Advisors Sergio Traversa - CEO & Director Maged Shenouda - Chief Financial Officer Charles Ence - Chief Accounting & Compliance Officer Conference Call Participants Andrew Tsai - Jefferies Yatin Suneja - Guggenheim Securities Joon Lee - Truist Securities Andrea Tan - Goldman Sachs Jay Olson - Oppenheimer Operator Greetings and welcome Relmada Therapeutics Inc. Th ...